{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T17:39:52Z","timestamp":1775669992903,"version":"3.50.1"},"reference-count":0,"publisher":"MJH Life Sciences","issue":"3512","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.46883\/2021.25920932","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T10:26:41Z","timestamp":1641378401000},"page":"816-819","source":"Crossref","is-referenced-by-count":1,"title":["Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell Tumor"],"prefix":"10.46883","member":"25947","published-online":{"date-parts":[[2021,12,17]]},"container-title":["ONCOLOGY"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T10:26:42Z","timestamp":1641378402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cancernetwork.com\/view\/management-of-residual-disease-after-first-line-chemotherapy-in-a-patient-with-a-nonseminomatous-germ-cell-tumor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":0,"issue-title":["December 2021"],"journal-issue":{"issue":"3512","published-online":{"date-parts":[[2021,12,9]]},"published-print":{"date-parts":[[2021,12,9]]}},"URL":"https:\/\/doi.org\/10.46883\/2021.25920932","relation":{},"ISSN":["0890-9091"],"issn-type":[{"value":"0890-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}